.png)
Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The Phase 3b SURMOUNT-5 (NCT05822830) open-label, 72-week long study in 751 adults directly compared tirzepatide (Zepbound) to semaglutide in patients without type 2 diabetes, but who have obesity or overweight with weight related comorbidities
Shipping, customer service, and the ordering experience Peptide Sciences handles logistics well
Dry mouth, headaches, and feeling tired can be common, but theyre usually temporary
Not all women experience the same results, some find that there are side effects associated with the medication such as nausea or headaches
US$ 28.80
US$ 26.86
US$ 25.46
US$ 27.25
